- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03080727
Intraobserver and Interobserver Reproducibility on Hip Clinical Assessment
October 24, 2017 updated by: Marco Aurélio Vaz, PhD, Federal University of Rio Grande do Sul
The functional assessment of the hip joint is complex and challenging.
Reproducible measures are necessary to identify changes in the structures and functionality of the hip joint over time and to evaluate the outcomes of treatments.
A systematic evaluation process is critical to evidence-based practice.
However, there are few studies investigating the reproducibility of these measures such as muscle strength, range of motion (ROM) and hip functionality in healthy subjects.
Study Overview
Status
Completed
Conditions
Detailed Description
Twenty subjects were randomized in two different days: (1) First evaluation of muscle strength, range of motion and single-leg squat performed by the evaluator 1; (2) Repeat the first evaluation with 3 different evaluators
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90690-200
- Exercise Research Laboratory, School of Physical Education, Federal University of Rio Grande do Sul
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Sampling Method
Non-Probability Sample
Study Population
Male healthy subjects
Description
Inclusion Criteria:
- No complaints of pain or knowledge of hip pathology
- Subjects willing to enroll
Exclusion Criteria:
- Subjects reporting that they can not perform the tests due to pain
- With previous surgery of the hip or pelvis;
- Diabetes Mellitus;
- Neuromuscular or neurological diseases;
- Cardiovascular diseases that prevent the realization of maximum voluntary effort;
- Subjects presenting positive hip clinical tests
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip muscle strength
Time Frame: Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
|
Measured with isometric hand hel dynamometry
|
Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip range of motion
Time Frame: Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
|
Measured with goniometer
|
Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Single-leg squat
Time Frame: Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
|
Hip adduction angle
|
Day 1 (evaluator 1) and after 4 days of rest repeat measures on day 2 with 3 different evaluators
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 13, 2017
Primary Completion (Actual)
May 19, 2017
Study Completion (Actual)
August 31, 2017
Study Registration Dates
First Submitted
March 9, 2017
First Submitted That Met QC Criteria
March 9, 2017
First Posted (Actual)
March 15, 2017
Study Record Updates
Last Update Posted (Actual)
October 26, 2017
Last Update Submitted That Met QC Criteria
October 24, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- UFRGS 1.822.689
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Joint
-
Smith & Nephew, Inc.RecruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Canada, Australia, Hong Kong, India
-
Rush University Medical CenterNYU Langone Health; Rothman Institute OrthopaedicsRecruiting
-
Rush University Medical CenterNew York University; Rothman Institute Orthopaedics; Keck School of Medicine...Recruiting
-
Northern Orthopaedic Division, DenmarkNot yet recruiting
-
Seoul National University HospitalRecruitingHip DislocationKorea, Republic of
-
OrthoCarolina Research Institute, Inc.CompletedHip Dislocation, Congenital | Congenital Deformity of Hip JointUnited States
-
RenJi HospitalNot yet recruitingFracture of Neck of Femur (Hip) | Femoral Head Necrosis | Dislocation of Hip Joint | Dysplasia of Hip Joint
-
University of AarhusCompleted
-
University of Southern DenmarkUnknownHip DislocationDenmark
-
University of British ColumbiaUnknown